Project Details
Description
NARRATIVE
Seizures and their progression can be prevented by metabolic therapy with a ketogenic diet – a disease-
modifying strategy with clinically significant benefits that have been observed consistently for nearly 100 years.
This benefit is not found with anticonvulsant drugs used to treat epilepsy, and evidence published by us and
others suggests that the ketogenic diet and one of its key anti-seizure mechanisms – the neuromodulator
adenosine – mobilizes lasting epigenetic changes that can prevent and reverse the clinical conditions known
as epilepsy. Here we quantify the ability of a ketogenic diet to prevent progression of epileptic seizures and
identify epigenetic mechanisms that restore and maintain normal brain activity.
Status | Finished |
---|---|
Effective start/end date | 9/15/10 → 4/30/22 |
Funding
- National Institute of Neurological Disorders and Stroke: $572,913.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.